Maleic Acid

Maleic Acid

SCHEMBL11332167

CN(C)[C@@H]1CC(Cl)CCC[C@H]1N(C(=O)CCCl)c1ccccc1.O=C(O)/C=C\C(=O)O

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2BTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3MPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PPARGSLC6A2SLC6A3SLC6A4SMOTYK2pol

The experimentally established mechanism targets of Maleic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A known ✓ P28223 2/20 0.35
▸ HTR2C known ✓ P28335 2/20 0.35
▸ HTR2B known ✓ P41595 2/20 0.35
▸ DRD2 known ✓ P14416 1/20 0.34
▸ SLC6A2 known ✓ P23975 1/20 0.33
▸ SLC6A4 known ✓ P31645 1/20 0.33
▸ SLC6A3 known ✓ Q01959 1/20 0.33
▸ ALDH1A1 P00352 3/20 0.42
▸ MITF O75030 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ PAX8 Q06710 1/20 0.42
▸ SIGMAR1 Q99720 3/20 0.35
▸ TRPM8 Q7Z2W7 2/20 0.35
▸ CHRM2 P08172 2/20 0.34
▸ CHRM3 P20309 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11332173 0.94 ALDH1A1 (0.46) ALDH1A1MITFSMN1; SMN2MEN1KMT2A
SCHEMBL11341207 0.94 ALDH1A1 (0.46) ALDH1A1MITFSMN1; SMN2MEN1KMT2A
SCHEMBL11336631 0.94 ALDH1A1 (0.46) ALDH1A1MITFSMN1; SMN2MEN1KMT2A
Hydrochloric Acid SCHEMBL11573548 0.93 ALDH1A1 (0.45) ALDH1A1MITFSMN1; SMN2MEN1KMT2A
Maleic Acid SCHEMBL11447588 0.92 NPC1 (0.40) ALDH1A1MITFSMN1; SMN2MEN1KMT2A
SCHEMBL11446684 0.86 ALDH1A1 (0.51) ALDH1A1MITFSMN1; SMN2MEN1KMT2A
SCHEMBL11446840 0.86 ALDH1A1 (0.45) ALDH1A1MITFSMN1; SMN2MEN1KMT2A
SCHEMBL11447829 0.86 ALDH1A1 (0.45) ALDH1A1MITFSMN1; SMN2MEN1KMT2A
SCHEMBL11465725 0.86 ALDH1A1 (0.45) ALDH1A1MITFSMN1; SMN2MEN1KMT2A
SCHEMBL11346058 0.86 MEN1 (0.41) ALDH1A1MITFSMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4156014-A N-(2-aminocycloheptyl)alkanoylanilides and in the treatment of depression THE UPJOHN COMPANY (US) 1979-05-22 — — US claimed
US-RE30837-E ANTIDEPRESSANTS THE UPJOHN COMPANY (US) 1981-12-29 — — US disclosed
US-4199589-A N-(2-Aminocycloheptyl)acylanilides and methods to treat depression SZMUSZKOVICZ JACOB (US) 1980-04-22 — — US disclosed
US-4169156-A ANTIDEPRESSANTS THE UPJOHN COMPANY (US) 1979-09-25 — — US disclosed
US-4159339-A ANTIDEPRESSANTS THE UPJOHN COMPANY (US) 1979-06-26 — — US disclosed
US-4156014-A N-(2-aminocycloheptyl)alkanoylanilides and in the treatment of depression THE UPJOHN COMPANY (US) 1979-05-22 — — US disclosed
Send feedback